MedTrace Logo

Validity and Reliability of the Turkish Version of the Post-Liver Transplant Quality of Life Questionnaire

NCT06577480 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 80

Last updated 2024-08-29

No results posted yet for this study

Summary

Liver transplantation is a crucial treatment for life-threatening liver diseases, including acute liver failure, end-stage chronic liver disease, primary liver cancers, and congenital metabolic disorders. Quality of life in liver transplant patients is vital. The World Health Organization defines quality of life as an individual's perception of their position in life within the context of culture, values, goals, and expectations. Liver transplantation improves quality of life. Recipients should be closely monitored and supported psychologically, with the effectiveness of the intervention in improving quality of life well-documented. Saab et al. developed the post-Liver Transplantation Quality of Life (pLTQ) questionnaire, which includes eight sub-dimensions across 32 items. To our knowledge, no Turkish-specific QoL tool for liver transplant patients currently exists. This study aims to validate and assess the reliability of the Turkish version of the pLTQ questionnaire.

Conditions

  • Liver Transplant Disorder
  • Quality of Life

Interventions

OTHER

No intervention

No intervention

Sponsors & Collaborators

  • Hacettepe University

    lead OTHER

Principal Investigators

  • Aslihan Cakmak-Onal, PhD, PT · Hacettepe University

  • Naciye Vardar-Yagli, PhD, PT · Hacettepe University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-06-26
Primary Completion
2026-06-26
Completion
2026-06-26

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06577480 on ClinicalTrials.gov